Seeking Alpha

  Acorda Therapeutics, Inc. (ACOR) - NASDAQ

  • StockConsultant | Send Message 18 Jun 2013

    $ACOR confirmed breakout above 34.83
      ACOR vs. ETF Alternatives
      Company Description
      Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States